Article

Papaverine targets STAT signaling: a dual-action therapy option against SARS-CoV-2

2024-11-18

Abstract excerpt

Papaverine (PV) has been previously identified as a promising candidate in SARS-CoV-2 repurposing screens. In this study, we further investigated both its antiviral and immunomodulatory properties. PV displayed antiviral efficacy against SARS-CoV-2 and influenza A virus (IAV) H1N1 and H5N1 in single infection as well as in co-infection. We demonstrated PV´s activity against various SARS-CoV-2 variants and identifi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 81eca174-d39c-57cf-a3c9-6605749e2453
DOI: 10.22541/au.173193504.47234671/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Papaverine targets STAT signaling: a dual-action therapy option against SARS-CoV-2DOI 10.22541/au.173193504.47234671/v1Read

DEVELOPING NEW DUAL-ACTION ANTIVIRAL/ANTI-INFLAMMATORY SMALL MOLECULES FOR COVID-19 TREATMENT USING IN SILICO AND IN-VITRO APPROACHESSemantic proximity Read

The Pan-African Natural Products Library Compounds Oleanolic Acid, Poinsettifolin B, and Rhuschalcone III Disrupt SARS-CoV-2 Spike-Host ACE2 Interactions and SARS-CoV-2 ReplicationSemantic proximity Read

PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and OmicronSemantic proximity Read

A vimentin-targeting oral compound with host-directed antiviral and anti-inflammatory actions addresses multiple features of COVID-19 and related diseasesSemantic proximity Read

Interferon alpha-based combinations suppress SARS-CoV-2 infection in vitro and in vivoSemantic proximity Read

Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like proteaseSemantic proximity Read

Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in severe COVID-19Semantic proximity Read

Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infectionSemantic proximity Read

Targeting conserved regions of the SARS-CoV-2 polymerase (RdRp) with kinase inhibitors as an effective new tactic for discovering dual-action "antiviral–antiinflammatory" drugs against COVID-19Semantic proximity Read

Nafamostat-interferon-alpha combination suppresses SARS-CoV-2 infection by targeting cooperatively host TMPRSS2 in vitro and in vivoSemantic proximity Read

Pyronaridine Protects Against SARS-CoV-2 in MouseSemantic proximity Read

Identification of an Antiviral Compound from the Pandemic Response Box that Efficiently Inhibits SARS-CoV-2 Infection In VitroSemantic proximity Read